Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis
Xiaodan Xu, Lu Zhang, Xiaogang He, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 502, Iss. 1, pp. 160-165
Closed Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge
Milica Nedeljković, Ana Damjanović
Cells (2019) Vol. 8, Iss. 9, pp. 957-957
Open Access | Times Cited: 678
Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment
Lihong Li, Rui Yu, Tiange Cai, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106939-106939
Closed Access | Times Cited: 270
TGF-β Signaling and Resistance to Cancer Therapy
Maoduo Zhang, Ying Yi Zhang, Yongze Chen, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Recent advances in targeted strategies for triple-negative breast cancer
Shuangli Zhu, Yuze Wu, Bin Song, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 113
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Paola Ferrari, Cristian Scatena, Matteo Ghilli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1665-1665
Open Access | Times Cited: 104
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 99
Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
Ming Yi, Yuze Wu, Mengke Niu, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005543-e005543
Open Access | Times Cited: 97
A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Hitesh Kumar, Neha Gupta, Rupshee Jain, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 271-292
Open Access | Times Cited: 59
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 58
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 50
Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
Kumar Ganesan, Cong Xu, Jianming Wu, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 9, pp. 1849-1866
Closed Access | Times Cited: 44
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response
Nasim Ebrahimi, Mahdokht Sadat Manavi, Ferdos Faghihkhorasani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 457-479
Closed Access | Times Cited: 27
TGF-β signaling: critical nexus of fibrogenesis and cancer
Anna O. Giarratana, Conor M. Prendergast, Mary Salvatore, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105401-105401
Open Access | Times Cited: 19
The role of photodynamic therapy on multidrug resistant breast cancer
Eric Chekwube Aniogo, Blassan P. George, Heidi Abrahamse
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 101
lncRNA GAS5‐promoted apoptosis in triple‐negative breast cancer by targeting miR‐378a‐5p/SUFU signaling
Shipeng Zheng, Mengquan Li, Keke Miao, et al.
Journal of Cellular Biochemistry (2019) Vol. 121, Iss. 3, pp. 2225-2235
Closed Access | Times Cited: 101
Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
Alireza Mafi, Malihe Rezaee, Neda Hedayati, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer
Sophie Poulet, Meiou Dai, Ni Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Cell signaling and cancer: a mechanistic insight into drug resistance
Munmun Panda, Bijesh K. Biswal
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5645-5659
Closed Access | Times Cited: 73
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
Snahlata Singh, Rumela Chakrabarti
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 642-642
Open Access | Times Cited: 67
Stem Cell Therapy for Burns: Story so Far
Najath Abdul Kareem, Ayesha Aijaz, Marc G. Jeschke
Biologics (2021) Vol. Volume 15, pp. 379-397
Open Access | Times Cited: 43
Combined chemotherapy for triple negative breast cancer treatment by paclitaxel and niclosamide nanocrystals loaded thermosensitive hydrogel
Deqian Zhao, Chenlu Hu, Qiang Fu, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 167, pp. 105992-105992
Closed Access | Times Cited: 42
TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation
Bikash Chandra Jena, Chandan Kanta Das, Indranil Banerjee, et al.
Experimental Cell Research (2022) Vol. 417, Iss. 1, pp. 113195-113195
Closed Access | Times Cited: 33
ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer
Mingcang Chen, Chunyu Wu, Zhengwei Fu, et al.
Cancer Science (2022) Vol. 113, Iss. 11, pp. 3751-3765
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top